Serum concentrations of insulin-like growth factor-I, insulin-like growth factor binding protein-3 and cardiovascular risk factors in adolescents

Annals of Clinical Biochemistry

Volumn 48, Issue 3, 2011, Pages 263-269

  Kong, Alice P S ^a   Choi, Kai Chow ^a   Wong, Gary W K ^a   Ko, Gary T C ^a   Ho, Chung Shun ^a   Chan, Michael H M ^a   Ozaki, Risa ^a   Ma, Ronald C W ^a   Lau, Joseph T F ^a   Chan, Juliana C N ^a  

^a CHINESE UNIVERSITY OF HONG KONG   (Hong Kong)

Author keywords

[No Author keywords available]

Indexed keywords

C REACTIVE PROTEIN; CREATININE; HEMOGLOBIN; INSULIN; SOMATOMEDIN BINDING PROTEIN 3; SOMATOMEDIN C; TRIACYLGLYCEROL;

ADOLESCENT; ADULT; ANTHROPOMETRY; ARTICLE; CARDIOVASCULAR RISK; CHEMOLUMINESCENCE; CHILD; CHINA; CREATININE BLOOD LEVEL; FEMALE; HUMAN; LIVER FUNCTION TEST; MAJOR CLINICAL STUDY; MALE; OBESITY; PRIORITY JOURNAL; SCHOOL CHILD; SYSTOLIC BLOOD PRESSURE; THYROID FUNCTION TEST; WAIST CIRCUMFERENCE;

ADOLESCENT; CARDIOVASCULAR DISEASES; CROSS-SECTIONAL STUDIES; DATA COLLECTION; FEMALE; HUMANS; INSULIN-LIKE GROWTH FACTOR BINDING PROTEIN 3; INSULIN-LIKE GROWTH FACTOR I; MALE; RISK FACTORS;

EID: 79956087497     PISSN: 00045632     EISSN: 00045632     Source Type: Journal    
DOI: 10.1258/acb.2011.010267     Document Type: Article

References (42)

1. Kong AP, Chan NN, Chan JC. The role of adipocytokines and neurohormonal dysregulation in metabolic syndrome. Curr Diabetes Rev 2006;2:397-407
2. Firth SM, Baxter RC. Cellular actions of the insulin-like growth factor binding proteins. Endocr Rev 2002;23:824-54
3. Mong JL, Ng MC, Guldan GS, et al. Associations of insulin-like growth factor binding protein-3 gene polymorphisms with IGF-I activity and lipid parameters in adolescents. Int J Obes (Lond) 2009;33:1446-53
4. Sandhu MS, Heald AH, Gibson JM, et al. Circulating concentrations of insulin-like growth factor-I and development of glucose intolerance: a prospective observational study. Lancet 2002;359:1740-5
5. Wallander M, Brismar K, Ohrvik J, et al. Insulin-like growth factor I: a predictor of long-term glucose abnormalities in patients with acute myocardial infarction. Diabetologia 2006;49:2247-55
6. Juul A, Scheike T, Davidsen M, et al. Low serum insulin-like growth factor I is associated with increased risk of ischemic heart disease: a population-based case-control study. Circulation 2002;106:939-44
7. Akanji AO, Suresh CG, Al-Radwan R, et al. Insulin-like growth factor (IGF)-I, IGF-II and IGF-binding protein (IGFBP)-3 levels in Arab subjects with coronary heart disease. Scand J Clin Lab Invest 2007;67:553-9
8. Gram IT, Norat T, Rinaldi S, et al. Body mass index, waist circumference and waist-hip ratio and serum levels of IGF-I and IGFBP-3 in European women. Int J Obes (Lond) 2006;30:1623-31
9. Yeap BB, Chubb SA, Ho KK, et al. IGF1 and its binding proteins 3 and 1 are differentially associated with metabolic syndrome in older men. Eur J Endocrinol 2010;162:249-57
10. Heid IM, Vollmert C, Kronenberg F, et al. Association of the MC4R V103I polymorphism with the metabolic syndrome: the KORA study. Obesity (Silver Spring) 2008;16:369-76
11. Tong PC, Kong AP, So WY, et al. Hematocrit, independent of chronic kidney disease, predicts adverse cardiovascular outcomes in Chinese patients with type 2 diabetes mellitus. Diabetes Care 2006;29:2439-44
12. Clemmons DR. Clinical utility of measurements of insulin-like growth factor 1. Nat Clin Pract Endocrinol Metab 2006;2:436-46
13. Daniels SR, Arnett DK, Eckel RH, et al. Overweight in children and adolescents: pathophysiology, consequences, prevention, and treatment. Circulation 2005;111:1999-2012
14. Kong AP, Wong GW, Choi KC, et al. Reference values for serum levels of insulin-like growth factor (IGF-1) and IGF-binding protein 3 (IGFBP-3) and their ratio in Chinese adolescents. Clin Biochem 2007;40:1093-9
15. Kong AP, Choi KC, Cockram CS, et al. Independent associations of alanine aminotransferase (ALT) levels with cardiovascular risk factor clustering in Chinese adolescents. J Hepatol 2008;49:115-22
16. Wong VW, Wong GL, Tsang SW, et al. Metabolic and histological features of non-alcoholic fatty liver disease patients with different serum alanine aminotransferase levels. Aliment Pharmacol Ther 2009;29:387-96
17. Friedewald WT, Levy RI, Fredrickson DS. Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge. Clin Chem 1972;18:499-502
18. Matthews RD, Hosker JP, Rudenski AS, et al. Homeostasis model assessment: insulin resistance and B cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia 1985;28:412-9
19. Leung SS, Cole TJ, Tse LY, et al. Body mass index reference curves for Chinese children. Ann Hum Biol 1998;25:169-74.
20. Ng VW, Kong AP, Choi KC, et al. BMI and waist circumference in predicting cardiovascular risk factor clustering in Chinese adolescents. Obesity (Silver Spring) 2007;15:494-503
21. Cook S, Weitzman M, Auinger P, et al. Prevalence of a metabolic syndrome phenotype in adolescents. Findings from the third national health and nutrition examination survey, 1988-1994. Arch Pediatr Adolesc Med 2003;157:821-7
22. Zimmet P, Alberti KG, Kaufman F, et al. The metabolic syndrome in children and adolescents - an IDF consensus report. Pediatr Diabetes 2007;8:299-306
23. Crossey PA, Jones JS, Miell JP. Dysregulation of the insulin/IGF binding protein-1 axis in transgenic mice is associated with hyperinsulinemia and glucose intolerance. Diabetes 2000;49:457-65
24. Borai A, Livingstone C, Zarif H, et al. Serum insulin-like growth factor binding protein-1: an improvement over other simple indices of insulin sensitivity in the assessment of subjects with normal glucose tolerance. Ann Clin Biochem 2009;46:109-13
25. Silha JV, Gui Y, Murphy LJ. Impaired glucose homeostasis in insulin-like growth factor-binding protein-3-transgenic mice. Am J Physiol Endocrinol Metab 2002;283:E937-45
26. Liu B, Lee HY, Weinzimer SA, et al. Direct functional interactions between insulin-like growth factor-binding protein-3 and retinoid X receptor-alpha regulate transcriptional signaling and apoptosis. J Biol Chem 2000;275:33607-13
27. Chan SS, Twigg SM, Firth SM, et al. Insulin-like growth factor binding protein-3 leads to insulin resistance in adipocytes. J Clin Endocrinol Metab 2005;90:6588-95
28. Schuler-Luttmann S, Monnig G, Enbergs A, et al. Insulin-like growth factor-binding protein-3 is associated with the presence and extent of coronary arteriosclerosis. Arterioscler Thromb Vasc Biol 2000;20:1175
29. Chang KH, Chan-Ling T, McFarland EL, et al. IGF binding protein-3 regulates hematopoietic stem cell and endothelial precursor cell function during vascular development. Proc Natl Acad Sci USA 2007;104:10595-600
30. Granata R, Trovato L, Lupia E, et al. Insulin-like growth factor binding protein-3 induces angiogenesis through IGF-I- and SphK1-dependent mechanisms. J Thromb Haemost 2007;5:835-45
31. Longobardi L, Torello M, Buckway C, et al. A novel insulin-like growth factor (IGF)-independent role for IGF binding protein-3 in mesenchymal chondroprogenitor cell apoptosis. Endocrinology 2003;144:1695-702
32. Collard TJ, Guy M, Butt AJ, et al. Transcriptional upregulation of the insulin-like growth factor binding protein IGFBP-3 by sodium butyrate increases IGF-independent apoptosis in human colonic adenoma-derived epithelial cells. Carcinogenesis 2003;24:393-401
33. Koc E, Bideci A, Cinaz P, et al. Insulin-like growth factor (IGF)-I and IGF-binding protein-3 in relation to hemoglobin concentration in healthy term infants. J Pediatr Endocrinol Metab 1997;10:609-13
34. Anttila R, Koistinen R, Seppala M, et al. Insulin-like growth factor I and insulin-like growth factor binding protein 3 as determinants of blood hemoglobin concentration in healthy subjects. Pediatr Res 1994;36:745-8
35. Wilson DM, Stene MA, Killen JD, et al. Insulin-like growth factor binding protein-3 in normal pubertal girls. Acta Endocrinol (Copenh) 1992;126:381-6
36. Landi F, Russo A, Capoluongo E, et al. Insulin-like growth factor-binding protein 3 and hemoglobin concentration in older persons living in the community. Int J Hematol 2007;85:294-9
37. Nilsson-Ehle H, Bengtsson BA, Lindstedt G, et al. Insulin-like growth factor-1 is a predictor of blood haemoglobin concentration in 70-yr-old subjects. Eur J Haematol 2005;74:111-6
38. Vihervuori E, Virtanen M, Koistinen H, et al. Hemoglobin level is linked to growth hormone-dependent proteins in short children. Blood 1996;87:2075-81
39. Bianchi C, Penno G, Malloggi L, et al. Non-traditional markers of atherosclerosis potentiate the risk of coronary heart disease in patients with type 2 diabetes and metabolic syndrome. Nutr Metab Cardiovasc Dis 2008;18:31-8
40. Wong GW, Leung SS, Law WY, et al. Secular trend in the sexual maturation of southern Chinese boys. Acta Paediatr 1996;85:620-1
41. Huen KF, Leung SS, Lau JT, et al. Secular trend in the sexual maturation of southern Chinese girls. Acta Paediatr 1997;86:1121-4
42. Wheatcroft SB, Kearney MT, Shah AM, et al. IGF-binding protein-2 protects against the development of obesity and insulin resistance. Diabetes 2007;56:285-94